ClinicalTrials.gov
public full text
Public Domain
Specific Immunotherapy for Allergic Child
The recent interest that the Specific Immunotherapy (ITS) has aroused is due to the positive potential role that could be played, in particular in the forms of allergic asthma, because this method constitute the only intervention (unlike that pharmacologic) able to act on the same causes of the disease, altering the natural history. To achieve this the investigator has tried to use the specific subcutaneous immunotherapy (SCIT), to which there are studies that, with scientific rigor, have demonstrated the benefits.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Corn Occupational Rhinitis SCIT Efficacy Study#845338
- Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract#1058919
- Study of 0417 Ointment in the Treatment of Atopic Dermatitis#863163
- Efficacy and Safety of Grazax in Children#1213650
- Meeting of the Strategic Advisory Group of Experts on Immunization, March 2026: conclusions and recommendations#256584
Record · ID 1365452
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive